The level of CD62E was highest in the AKI-2 group, and the level of VCAM-1 was highest in the AKI-3 group, followed by the AKI-2 and AKI-1 groups but without a statistical difference (P > 0.05). This evidence concerns the gene VCAM1 and acute kidney injury.